MANGALAM DRUG & CHEM LTD
Latest filings
- Mangalam Drugs revenue nearly doubles, but September-quarter loss persists · Compliance
- Quarter ended Sep 2026: consolidated revenue up 61% from year ago, but net loss Rs 721 lakh · Results
- September quarter: consolidated revenue rises 61%, but losses and debt risk persist · Results
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹262 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Nothing stands out in the filed numbers.Concerns
Charts
How has the market priced it — with filings on the timeline?
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from MANGALAM DRUG & CHEM LTD's filed financials and exchange disclosures
What does MANGALAM DRUG & CHEM LTD do?
MANGALAM DRUG & CHEM LTD is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol MANGALAM.
Is MANGALAM DRUG & CHEM LTD profitable?
No. Over the trailing twelve months MANGALAM DRUG & CHEM LTD reported a net loss of ₹38 Cr on revenue of ₹262 Cr.
Does MANGALAM DRUG & CHEM LTD pay a dividend?
Not in the latest reported year — MANGALAM DRUG & CHEM LTD's dividend payout for FY26 was nil.
Is MANGALAM DRUG & CHEM LTD debt-free?
No. It reported borrowings of ₹88 Cr on its 30 Sept 2026 balance sheet, or net debt of ₹87 Cr after cash. Debt stands at 1.02× equity. That is higher than 93% of its 166 Pharmaceuticals peers.
How much does the MANGALAM DRUG & CHEM LTD share price move in a day?
On a typical session MANGALAM DRUG & CHEM LTD moves 1.86% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.
Where can I track MANGALAM DRUG & CHEM LTD's announcements?
Every NSE and BSE filing by MANGALAM DRUG & CHEM LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.